Animal & Veterinary

2012 Letters

Company Name Subject Type of Action Date of Action Issuing Office Product(s) Addressee Location File
Sogeval Laboratories, Inc. CGMP regulation deviations and unapproved new drugs UL 3/12/2012 Dallas District Office topical drug products TX HTML
Merck Animal Health Promotional Claims UL 4/9/2012 CVM NADA 141-299, Resflor Gold (florfenicol and flunixin meglumine) NJ HTML
Clavel Corporation CGMP regulation deviations and unapproved new drug UL 9/18/2012 Dallas District Office Blue Stop-E, topical pain reliever TX HTML
ProCore Laboratories, LLC CGMP regulation deviations and unapproved new drug UL 9/25/2012 Dallas District Office Douxo Chlorhexidine PS Microemulsion Spray, topical antimicrobial TX HTML
Intervet Inc. (d/b/a Merck Animal Health) Promotional Claims UL 10/16/2012 CVM NADA 141-305, Orbax (orbifloxacin) Oral Suspension NJ PDF

Page Last Updated: 07/10/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English